Quick Answer
Hyperbaric oxygen therapy for Lyme disease has **no published randomized controlled trials* supporting its use — the entire evidence base consists of small case reports and case series, mostly from the 1990s. It is not recommended by the Infectious Diseases Society of America (IDSA) or endorsed by the CDC as a treatment for Lyme disease or chronic Lyme symptoms. This is one of the weakest evidence categories in hyperbaric medicine, and we think patients deserve to know that clearly before spending money on it.
Why HBOT Gets Associated With Lyme Disease
The theory behind HBOT for Lyme rests on a specific biological claim: that Borrelia burgdorferi, the bacterium responsible for Lyme disease, is anaerobic (oxygen-averse) and might be killed or suppressed by the high-oxygen environment inside a hyperbaric chamber. This is a reasonable-sounding hypothesis — HBOT genuinely does have bactericidal effects against certain anaerobic organisms, which is part of why it’s FDA-approved for conditions like gas gangrene and necrotizing soft tissue infections.
The problem is that a plausible mechanism is not the same as clinical proof, and B. burgdorferi*’s actual oxygen tolerance is more complex than the simplified “anaerobic bacteria” framing suggests.
What the Evidence Actually Shows
| Evidence Type | What Exists |
|---|---|
| Randomized controlled trials | None published |
| Case reports / case series | A small number from the 1990s (e.g., Fife & Fife, Undersea & Hyperbaric Medicine) — no control group, no blinding |
| Systematic reviews | None specifically evaluating HBOT for Lyme disease |
| Professional guidelines | IDSA/AAN/ACR 2020 Lyme disease guidelines do not recommend HBOT |
| Regulatory status | Not an FDA-approved indication |
This puts HBOT for Lyme in a fundamentally different evidence category than topics like HBOT for stroke recovery or Long COVID, where at least some randomized, sham-controlled trials exist — even if results are mixed. For Lyme disease, that level of evidence simply doesn’t exist yet.
The “Chronic Lyme” Complication
Part of why this topic is confusing is the ongoing medical debate around “chronic Lyme disease” or “post-treatment Lyme disease syndrome” (PTLDS) — persistent fatigue, joint pain, and cognitive symptoms some patients report after standard antibiotic treatment for confirmed Lyme disease. Mainstream infectious disease guidelines don’t recognize prolonged antibiotic courses (or HBOT) as effective for these lingering symptoms, while some practitioners in the “Lyme-literate” community continue to recommend both, often outside standard treatment guidelines.
We’re not going to adjudicate that broader medical controversy here. What we can say clearly: **no controlled clinical trial has tested HBOT specifically for PTLDS or chronic Lyme symptoms*, so any claims about its effectiveness for this population are not evidence-based, regardless of how confidently they’re marketed.
What We’d Tell a Patient Asking About This
If you’re dealing with confirmed Lyme disease, the evidence-based path is standard antibiotic treatment per IDSA guidelines, prescribed by an infectious disease specialist. If you’re dealing with persistent symptoms after treatment, that’s a conversation for your physician about ruling out other causes — not a decision to make around hyperbaric equipment with no controlled trial data behind it for this specific use.
We manufacture mild hyperbaric chambers (1.1–1.7 atm) for general wellness use, and we’re not going to market them as a Lyme disease treatment — the evidence doesn’t support that claim, full stop. If a wellness routine involving relaxation and oxygen-enriched rest is something you’re independently interested in as part of general health maintenance, our AURA One is built for that kind of quiet home use — but that’s a wellness decision, not a treatment decision for Lyme disease.
FAQ
Q: Is there scientific proof HBOT treats Lyme disease?
No. There are no published randomized controlled trials testing HBOT for Lyme disease. The existing evidence consists of small, uncontrolled case reports from the 1990s, which cannot establish whether the therapy actually works.
Q: Do infectious disease doctors recommend HBOT for Lyme disease?
No. The IDSA/AAN/ACR 2020 clinical practice guidelines for Lyme disease do not include HBOT as a recommended treatment.
Q: Can HBOT help with chronic Lyme or post-treatment Lyme symptoms?
There is no controlled clinical trial evidence evaluating HBOT specifically for persistent post-treatment Lyme symptoms. Claims of effectiveness for this population are not supported by published research.
Q: Why do some clinics still offer HBOT for Lyme disease?
Some practitioners rely on the biological plausibility argument (that anaerobic bacteria may be oxygen-sensitive) and older case reports, despite the absence of controlled trials. Patients should understand this distinction between a plausible theory and clinical proof before pursuing treatment.
This article is for educational purposes only and is not medical advice. HBOT is not an FDA-approved or IDSA-recommended treatment for Lyme disease. Anyone with a suspected or confirmed Lyme disease diagnosis should consult an infectious disease physician for evidence-based treatment. HyperbaricO2Care manufactures mild hyperbaric chambers (1.1–1.7 atm) intended for general wellness use and does not market or recommend its equipment as a Lyme disease treatment. Reference: IDSA/AAN/ACR Clinical Practice Guidelines for Lyme Disease (2021 update).*
Explore our chambers: AURA One (Home) · View All Products